Breaking
🇺🇸 FDA
Health Canada Approves Bracco's VUEWAY (Gadopiclenol) for Lower-Dose MRI Contrast Imaging
NewsApr 18, 2026

Health Canada Approves Bracco's VUEWAY (Gadopiclenol) for Lower-Dose MRI Contrast Imaging

Health Canada approves Bracco's VUEWAY injection (gadopiclenol) for MRI contrast imaging, enabling lower gadolinium doses while maintaining diagnostic quality.

Dr. Sarah Mitchell
Re:Cognition Health Launches International Clinical Trial for Revolutionary Finger-Prick Alzheimer's Blood Test
NewsAlzheimer's Disease DiagnosticsApr 16, 2026

Re:Cognition Health Launches International Clinical Trial for Revolutionary Finger-Prick Alzheimer's Blood Test

Re:Cognition Health begins landmark international trial testing finger-prick blood biomarker test for early Alzheimer's diagnosis, potentially replacing invasive methods.

James Chen, PharmD